4//SEC Filing
NAVIDEA BIOPHARMACEUTICALS, INC. 4
Accession 0001638599-16-000697
CIK 0000810509operating
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 5:23 PM ET
Size
5.4 KB
Accession
0001638599-16-000697
Insider Transaction Report
Form 4
LARSON BRENT L
VP Finance and CFO
Transactions
- Award
Stock Option (Right to Buy)
2016-02-25+54,501→ 54,501 totalExercise: $0.98From: 2016-02-26Exp: 2026-02-25→ Common Stock (54,501 underlying)
Footnotes (1)
- [F1]Granted in lieu of cash bonus under 2015 bonus plan.
Documents
Issuer
NAVIDEA BIOPHARMACEUTICALS, INC.
CIK 0000810509
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000810509
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Feb 29, 5:23 PM ET
- Size
- 5.4 KB